Login
$XLAB
$3.17 +$0.09 (2.92%) Close

$XLAB 8-K SEC Filings

Filed On Filing
15 Oct 2026 8-K: Entry into a Material Definitive Agreement

Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential; such information has been marked with “[***]”. Certain personally i...

30 Sep 2026 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Effective September 25, 2026, Gildas Bonnier ceased serving as the Interim Chief Financial Officer of Exascale Labs Holdings Inc. (the “Company”).

28 Sep 2026 8-K: Results of Operations and Financial Condition

Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing

08 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

On September 4, 2026, Exascale Labs Holdings Inc. (the “Company”) appointed Gildas Bonnier as Interim Chief Financial Officer of the Company, effective as of September 4, 2026. In his position as Interim Chief Financial Officer, Mr. Bonn...

02 Sep 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +9 more

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support